Paul Leinwand

Dr. Sanjeev Sockalingam, a leading expert on obesity and GLP-1 medications, joins Paul Leinwand, a strategy consultant focused on how these drugs impact consumer behavior. They discuss the upcoming arrival of generic GLP-1s in Canada, which could drastically reduce costs and reshape how Canadians approach their health and spending. The conversation highlights shifts in consumer habits, including changes in grocery purchases and even dating, while addressing the stigma surrounding obesity treatments and the societal implications of these medications.